Abstract: T cell immune responses are driven by the recognition of peptide antigens (T cell epitopes) that are bound to major histocompatibility complex (MHC) molecules. T cell epitope immunogenicity is thus contingent on several events, including appropriate and effective processing of the peptide from its protein source, stable peptide binding to the MHC molecule, and recognition of the MHC-bound peptide by the T cell receptor. Of these three hallmarks, MHC-peptide binding is the most selective event that determines T cell epitopes. Therefore, prediction of MHC-peptide binding constitutes the principal basis for anticipating potential T cell epitopes. The tremendous relevance of epitope identification in vaccine design and in the monitoring of T cell responses has spurred the development of many computational methods for predicting MHC-peptide binding that improve the efficiency and economics of T cell epitope identification. In this report, we will systematically examine the available methods for predicting MHC-peptide binding and discuss their most relevant advantages and drawbacks.
INTRODUCTION
Classical major histocompatibility complex (MHC) molecules play a pivotal role in the adaptive immunity mediated by the T cells. T cell immune responses are induced by the T cell receptor (TCR) mediated recognition of antigenic peptides that are bound to MHC molecules expressed on the surface of antigen-presenting cells (APCs) [1, 2] . T cells that recognize self-peptides are eliminated during the process of thymic selection; therefore, the primary targets of T cell immune recognition (reviewed in ref. [3] ) are MHC molecules incorporating foreign peptides.
MHC molecules fall into two major classes -MHC class I (MHCI) and MHC class II (MHCII) [4] . MHC class I (MHCI) molecules are expressed on most nucleated cells, generally bind peptides processed from endogenously synthesized antigens, and are recognized by CD8 T cells. Activated CD8 T cells become cytotoxic T lymphocytes (CTLs) that recognize and kill host target cells that express MHCI-bound antigenic peptides (e.g., infected and tumor cells).
In contrast, MHC class II (MHCII) molecules are expressed mostly on professional APCs, bind peptides that are processed from extracellular antigens, and are recognized by CD4 T cells. Recognition of MHCII-peptide complexes stimulates the regulatory helper functions of CD4 T cells, which acquire T H 1 or T H 2 phenotypes that orchestrate the immune response [5, 6] . T H 1 immune responses activate phagocytes, NKs and CD8 T cells, and are essential for In humans, MHC molecules are known as HLAsHuman Leukocyte Antigens-and are encoded by the HLA region on chromosome 6p21.3. There are three types of classical HLA class I (HLA I) molecules (HLA-A, HLA-B, and HLA-C), as there are for classical HLA class II (HLA II) molecules (HLA-DP, HLA-DQ, and HLA-DR). HLA gene expression is codominant, and an individual typically expresses 6 different HLA I molecules and 12 or more different HLA II molecules. In the entire population, there are hundreds of different HLA alleles, rendering the HLA locus the most polymorphic gene system known [2] . The HLA IMGT/HLA database [7] currently includes 3528 HLA allelic sequences (2496 HLA I alleles and 1032 HLA II alleles) (release 2.25, 04/2009). Each individual HLA molecule binds a large repertoire of peptides estimated to range from 1,000 to 10,000 individual sequences [8] , and because peptide binding specificity is determined by the HLA polymorphism [9] , HLA allelic variants generally bind distinct sets of peptides.
The identification of both CD8 and CD4 T cell epitopes is important in understanding disease pathogenesis [10] . Moreover, it is the basis for the development of epitopebased vaccines against infectious agents [11] and treatments for allergic [12] , autoimmune [13] and neoplastic diseases [14] . Traditionally, the identification of T cell epitopes required the synthesis of overlapping peptides that spanned the entire length of a protein, followed by experimental assays for each peptide, such as in vitro intracellular cytokine staining [15] , to determine T cell activation. This method is economically viable only for single proteins or pathogens that consist of several proteins. As a result, alternative computational approaches have been developed for the prediction of T cell epitopes, which have significantly decreased the experimental burden that is associated with epitope identification.
Peptide binding to MHC is a prerequisite for T cell recognition and is, in addition, the event that most selectively defines T cell epitopes [16] . Therefore, the prediction of T cell epitopes relies primarily on predicting MHC-peptide binding. Many models and methods have been developed to predict peptide binding to MHC molecules, using different types of peptide binding data and algorithms. Notably, the same algorithm trained on data of different nature (e.g. quantitative versus qualitative data) will yield contrasting models. Moreover, completely different techniques can result in models that, despite resembling formats, are intrinsically unrelated (e.g. motif matrices and quantitative matrices). This complexity makes the description and classification of the disparate methods for predicting MHCpeptide binding somewhat difficult, and has led to some confusion in the literature. To avoid such confusion, in this review, we will carry out a comprehensive overview of the different methods to predict MHC-peptide binding, following a classification schema that focuses primarily on the type of data used for training.
STRUCTURAL BASIS OF MHC-PEPTIDE BINDING
The three-dimensional (3D) structures of classical MHCI and MHCII molecules are strikingly similar despite sharing minimal sequence similarity (< 20% identity). MHCI molecules are heterodimers consisting of a single membranespanning chain that is paired with the soluble 2 microglobulin ( 2m) protein. The peptide-binding domain of the MHCI molecule, formed by the distal 1 and 2 segments of the chain ( 1 2 domain), consists of twohelices that lie above a floor composed of eight antiparallel -stranded sheets (Fig. 1A) .
MHCII molecules are also heterodimers, but they consist of two membrane-spanning chains, -the and chains. The distal membrane regions of the and chains ( 1 and 1 segments) fold together to form the peptide-binding domain (Fig. 1B) , which closely resembles that of the MHCI [17, 18] . Yet, there are key structural differences between the peptide-binding domains of MHCI and MHCII molecules that allow them to bind peptides in completely different modes.
MHCI-peptide ligands are short (8-11 amino acids) and their N-and C-terminal ends are connected to conserved residues of the MHCI molecule through a network of hydrogen bonds [19] [20] [21] (Fig. 1A) . The MHCI binding groove contains deep binding pockets that are delineated by polymorphic side-chains [9] in which specific peptide side chains fit (anchor residues). Generally, positions 2 and 3, and the C-terminus of the peptides that bind to MHCI are anchor positions (Fig. 1A ) [21] , although the preferences for specific residues at anchor positions vary between MHCI molecules. Fig. (1) . Binding of peptide ligands to MHCI and MHCII molecules. This figure shows the top of the molecular surface of the antigenpresenting platform of representative human MHCI (A) and MHCII (B) molecules as viewed by the T cell receptor. The MHCI molecule corresponds to HLA-A*0201 in complex with the peptide LLFGYPVYV from HTLV-1 TAX protein (PDB: 1HHK). The MHCII molecule corresponds to HLA-DR1 in complex with the peptide PKYVKQNTLKLAT from influenza hemagglutinin protein (PDB:1FYT). Peptides bound to these molecules are represented by sticks to highlight the contours of the binding groove. Note how the peptide binding groove of the MHCI molecule is closed, and peptides bind in a manner such that both, the N-terminal and C-terminal ends of the peptide (indicated by arrow heads) are nestled into the MHCI binding groove, restricting their length to 8-11 residues. In contrast, the binding groove of the MHCII molecule is open, thereby imposing no limitation on the size of peptide ligands, whose N-terminal and C-terminal ends can extend beyond the binding groove. The side chains of N-terminal and C-terminal ends of the 9-mer peptide core that fits into the MHCII binding groove are indicated by arrow heads. The general binding mode of peptides to MHCI and MHCII is shown at the right corner of panels A and B. In this representation, peptide positions contacting the TCR and MHC are shaded in red and blue, respectively and are also indicated with opposing arrows. Positions shaded in grey can be anchor or TCR contact positions, depending of the specific MHC molecule. The figure was prepared using GRASP [122] .
Because the geometry and chemical environment of the MHCI binding pockets impose tight constraints on the residues and overall peptide length to achieve binding, predicting MHCI-peptide binding is relatively simple and historically has progressed faster than that for MHCII molecules [22] . It is worth noting that peptides that have different sizes and bind to the same MHCI molecule often use alternative binding pockets [23] ; therefore methods for predicting MHCI-peptide binding are specific for a fixed peptide length. However, most MHCI-peptide ligands have nine residues (they are 9-mers), making models for the prediction of 9-mer binders preferable.
In contrast to MHCI molecules, the peptide-binding groove of MHCII molecules is open, allowing the N-and Cterminal ends of a peptide to extend beyond the binding groove (Fig. 1B) . As a result, MHCII-bound peptides vary widely in length (9-22 residues), although only a core of nine residues (peptide-binding core) fits into the MHCII binding groove. The MHCII binding groove is shallower than that of MHCI, but it also has pockets that are outlined by polymorphic residues in which peptide side chains nestle. Typically, positions 1 and 9 of the peptide-binding core of MHCII-bound peptides are anchor positions [24] (Fig. 1B) . A major contribution to the overall binding of peptide to MHCII [18, 19, 25] is due to a set of conserved hydrogen bonds that lie between the backbone of the peptide core and the MHCII molecule [18, 19, 25] . With regard to these properties, MHCII molecules impose relatively weak limitations on peptide side chains, harboring broader peptidebinding repertoires than MHCI molecules. This quality along with the variable length of the MHCII-peptide ligands, complicates the identification of MHCII-peptide binding motifs and the generation of peptide binding models in general. Most MHCII-peptide binding models assume that the peptide-binding core alone determines the binding energy. Therefore, the generation of such models usually includes a preliminary step that identifies the binding core of the peptides. This step is an oversimplification, however, because there is evidence that the peptide-binding core flanking residues (PFRs) contribute to the overall binding [26] .
PREDICTION OF MHC-PEPTIDE BINDING
There are myriad methods and models for predicting MHC-peptide binding, which differ in the techniques and algorithms that are applied as well as on the nature of the data used for training. However, the methods to predict MHC-peptide binding are generally described with regard to the techniques and algorithms used to develop them, which has led to some confusion in the literature. Instead, here we will review the different MHC-peptide binding prediction methods following a system that focus primarily on the type of data used for training (Fig. 2) . Under this scope, methods to predict MHC-peptide binding can be first classified in two overarching groups: those generated from sequences of peptide binders (sequence-based models or peptide-data driven models), and those that do not require any peptide binding data and are based solely on the sequence and structure of MHC molecules (modeling-based methods). Sequence-based models can also be divided in two types: those based on qualitative data that describe the ability of peptides to bind to MHC molecules (e.g. binders and nonbinders) and those trained on quantitative data consisting of peptides whose binding affinity for MHC molecules has been determined. Qualitative data will only produce qualitative binding models that will predict, with some certainty, whether a test peptide binds to a given MHC molecule. Essentially, qualitative models try to recognize the binding pattern/feature that is present on the peptides used for training: therefore we will hereafter refer to them as binding pattern recognition models. In contrast, one can develop quantitative regression models from peptides that have known binding affinities to MHC molecules. These models target the prediction of the actual binding affinity of peptides to MHC; thus, we term these methods quantitative binding affinity models.
Binding Pattern Recognition Models

Sequence Motifs
A sequence motif is the simplest method of representing the peptide binding motif of a specific MHC molecule. It consists of a symbolic peptide string that lists the amino acid preferences of the MHC molecule at each position of the peptide. The first peptide binding motifs were obtained by pool sequencing of peptide ligands eluted from MHCI molecules [22] . In general, however, peptide binding motifs are identified by comparing sets of peptide sequences that are known to bind to MHC molecules [22, 27] . The largest collection of peptide binding motifs for MHCI and MHCII molecules is stored in the SYFPEITHI database [27] .
MHC allele-specific peptide binding motifs were the first models to enable accurate identification of MHCI restricted T cell epitopes [28, 29] , and they remain widely used (Table  I ). Yet, the use of sequence motifs is too simplistic, because residues that do not reside at anchor positions also contribute to binding [30, 31] . Moreover, sequence motifs are too rigid to predict MHC-peptide binding, yielding many false negatives.
Motif Matrices
Motif matrices represent an enhancement of sequence motifs. Examples of motif matrices were first developed by De Groot et al. [32] and Rammensee et al. [27] (Table I) . These matrices consist of tables whose coefficients are associated with the position-specific amino acid frequencies found on peptides that bind to a specific MHC molecule. For any peptide sequence, the binding score is calculated by summing the relevant position and residue-matched matrix coefficients. Peptide biding scores that are generated using motif matrices are continuous; therefore, a binding threshold is required to distinguish the true binders.
Related to motif matrices are the profiles developed by Reche et al. [33] [34] [35] from sets of aligned peptides that bound to specific MHC molecules. These profiles are readily available for free public use at the RANKPEP site [33] ( Table I) . Profiles --also known as position-specific scoring matrices (PSSMs)-were first introduced in 1987 by Gribskov et al. [36] to detect distantly related sequences and basically consist of log-odds matrices whose coefficients are (1) The server allows multiple (n) selections of MHC molecules for peptide binding predictions. logarithm ratios of observed amino acid frequencies with respect to the relevant background frequencies. Unlike basic motif matrices, profiles also correct for sequence redundancies (through sequence weights) and missing data (using pseudo-counts that are estimated from substitution matrices). RANKPEP MHCII-specific profiles were generated from peptide-binding cores that were identified from MHCIIpeptide ligands using an expectation-maximization motif discovery program [37] . Virtually identical to these PSSMs are the weight-matrices latter described by Nielsen et al. [38] .
All of the motif matrices described above were developed solely from positive examples that consisted of known MHC-binding peptides. In contrast, Mallios [39] described a motif matrix to predict peptide binding to HLA-DR molecules that was generated from positive and negative data using an stepwise discriminating analysis (SDA). Mallios [39] described this method as quantitative, because, in contrast to sequence patterns, it yielded continuous scores that discriminated peptides as binders and non-binders. The method, however, was not trained on quantitative binding affinity but on qualitative data; thus it cannot predict peptide binding affinities.
The prediction of MHC-peptide binding using motif matrices and sequence motifs assumes that peptide residues contribute independently to binding. Such an assumption, in general, is well supported by experimental data, but there is also evidence indicating that the contribution of peptide residues to MHC-binding is influenced by neighboring residues [40] .
Machine Learning-Based Motifs
Machine learning algorithms (MLAs) can handle nonlinear data and capture binding interferences between peptide residues. Using MLAs, peptide binding motifs are learned under a classification schema, in which MLAs are trained on positive (e.g., peptide binders) and negative (e.g., nonbinders) sets of examples. Experimental data on non-binding peptides generally are unavailable, and randomly selected peptides from a large database often are used instead. MLAs can also learn more complex patterns under a multiclass classification, in which they are trained on MHC-binding peptides that are grouped into more than two classes (e.g., high binders, intermediate binders, weak binders, and nonbinders).
Artificial Neural Networks (ANNs) are one of the MLAs most frequently applied to the recognition of MHC-peptide binding patterns. ANNs are connectionist models that commonly are used in biology for classification and pattern recognition [41] . ANNs were introduced first to predict peptide binding to MHCI -specifically to HLA-A*0201 [42, 43] and K b [44] (a mouse MHCI molecule)-and latter extended to MHCII with HLA-DR4(DRB1*0401) [45, 46] . These models for peptide binding prediction to MHCII were trained on peptide-binding cores, which were identified prior to training the ANNs. To this end, Brusic et al. [46] devised a system that used an automated evolutionary algorithm to identify the peptide-binding core of MHCII-peptide binders, which were subsequently fed to an ANN. Predictions of peptide binding to MHC molecules using ANN-based motifs can be made at the MULTIPRED site (Table I) .
Support vector machines (SVMs) have also been applied to recognize MHC-peptide binding. SVMs are a relatively new type of MLA that are increasingly being used in the life sciences to identify patterns [47] [48] [49] ; they classify by constructing an N-dimensional hyperplane that separates the data optimally into categories. Using this approach, Donnes and Elofsson [50] developed the SVMHC method (Table I) , which is available online to predict peptide binding to MHCI. Later, Bhasin and Raghava [51] used a similar SVMbased approach to predict peptide binding to HLA-DR4 (DRB1*0401).
Peptide input data used for training SVMs, and in general to any MLA, can be encoded into different formats, wherein the only limitation is that each peptide needs to be represented by a fixed length vector. Frequently, peptides are represented in binary format, but recently Tung and Ho [52] used the physicochemical properties of peptides known to bind to MHCI molecules as input data for SVMs, developing the POPI method (Table I) . Similarly, Salomon and Flower [53] predicted MHCII-peptide binding using a kernel-based SVM that was trained on the similarity scores of MHCII allelic-specific peptide ligands. Notably, Salomon and Flower [53] did not preprocess the MHCII-peptide binders to identify the peptide-binding core; thus their method also can model the influence of PFRs (peptide-binding core flanking residues) on binding.
The unavailability of peptide binding data always limits the development of allelic-specific MHC-peptide binding predictors. Interestingly, Jacob and Vert [54] combined the routine SVM formulation, described by Donnes and Elofsson [50] , with an user-defined measure of similarity between alleles, which allowed for the estimation of peptide binding to MHCI alleles with few known binders. Jacob and Vert's [54] predictive models are readily available at the KISS site ( Table I) .
Decision trees (DTs) are one of the most popular classification algorithms [55] and they also have been applied to predict MHC-peptide binding. In this approach, the DT is used to construct a graph model of the MHC-peptide binding motif, which subsequently can be used to decide whether a test peptide fits into that motif. Savoie et al. [56] were the first to report the use of BONSAI DTs to predict peptide binding for HLA-A*0201. A similar tree-structured technique was later reported by Segal et al. [57] to predict peptide binding to K b (a mouse MHCI molecule). More recently, Zhu et al. [58] trained DTs using peptide binding data from different MHCI molecules simultaneously, which improved the prediction accuracy of peptides that bind to a specific MHCI molecule.
Hidden Markov Models Motifs
The Hidden Markov model (HMM) is the most widely used technique in speech and sequence pattern recognition [59, 60] . HMMs are based on parametric statistical models, wherein the system that is being modeled is assumed to be connected by a Markov chain of unknown hidden parameters that are obtained from the observable data. HMMs can cope with non-linear data. However, unlike the MLAs that we have described, they can be trained only on positive data.
Three types of HMMs have been used to predict MHCpeptide binding: fully connected HMMs [61] , structureoptimized HMMs [62, 63] , and profile HMMs [63] . Fully connected HMMs (fcHMMs) were the first to be applied to predict MHC-peptide binding, specifically to HLA-A*0201 [61] . fcHMMs have the greatest potential to model nonlinear data, recognizing different patterns in the peptide binders that are used for training, but they carry high computing costs. Profile HMMs (pHMMs) are derived from sets of aligned peptides using tools such as the HMMER and SAM packages [64] . pHMMs perform dramatically fewer computations than fcHMMs but are much weaker in modeling different patterns. In fact, pHMMs that are derived from sets of ungapped alignments (the case for peptides binding to MHC) are nearly identical to profile matrices [65] . In structure-optimized HMMs (soHMMs), the model's connectivity is greatly reduced with regard to fcHMMs, and yet they have some capacity to model non-linear data. HMMs used to predict peptide binding to MHCI and MHCII molecules are implemented in the MULTIPRED method [66] (Table I) .
Quantitative Binding Affinity Models
Quantitative Additive Models
Quantitative matrices (QMs) are the most widely used additive models in predicting MHC-peptide binding. QMs resemble motif matrices, but, in contrast to motif matrices, they are generated from actual peptide binding affinity data. Therefore, peptide scores computed with QMs are intended to reflect actual binding affinities to MHC. The first QMs were derived by Parker et al. [67] for MHCI molecules, and they are implemented by the BIMAS method (BIMAS-QMs) ( Table I) . Parker et al.'s [67] QMs were generated from limited numbers of peptides.
QMs for predicting peptide binding to MHC molecules have also been developed using binding affinity data obtained from positional scanning combinatorial peptide libraries (PSCPLs) [68, 69] . In this approach, all possible peptides of a given length are represented by sets of sublibraries, and in each sublibrary, one amino acid is fixed and the remaining positions contain mixtures of all amino acids. The coefficients of QMs that are generated using PSCPLs typically are logarithmic peptide concentrations relative to a reference peptide library.
Several other methods have been used to construct QMs from large sets of binding affinity data of peptides to MHC. Bui et al. [70] used the Average Relative Binding (ARB) method to derive QMs (ARB-QMs) to predict the binding affinity of peptides to MHCI and MHCII (Table I) . Similarly, Peters et al. [71] have used a Stabilized Matrix Method (SMM) to generate QMs (SMM-QMs) from peptide binding affinity data, which was first applied to HLA-A*0201 [40] . For MHCII molecules, Nielsen et al. [72] used a novel SMM approach (SMM-align) to predict peptide binding affinity. Interestingly, Nielsen et al.'s [72] included the two most proximal PFRs to the peptide-binding core into their models, which improved their predictive performance.
Closely related with to QMs are the virtual QMs that were derived by Sturniolo et al. [73] to predict peptide binding affinity to HLA-DR molecules. These authors used peptide libraries to obtain a quantitative representation of the interaction of all natural amino acid residues with structurally identified binding pockets of HLA-DR molecules (pocket binding profile). Subsequently, they showed that the binding affinity of a peptide to any HLA-DR allele can be predicted by selecting the appropriated binding pocket profiles, using the TEPITOPE [74] system. TEPITOPE QMs are readily available for free public use at the PROPRED site ( Table I) .
As motif matrices, QMs assume an independent contribution of peptide side chains to MHC binding. In contrast, Doytchinova and colleagues [75, 76] used partial least squares (PLS), a robust multivariate statistical method, to derive quantitative structure activity relationship (QSAR) additive models, wherein the binding affinity of peptides to MHC is computed as the sum of amino acid contributions at each position plus the contribution of adjacent side chains interactions. PLS models for predicting peptide binding affinity to MHCI and MHCII molecules is implemented using the MHCPRED method [77] (Table I) .
Machine Learning-Based Regression Models
Machine Learning regression models for predicting the binding affinity of peptides to MHC result from regression training of MLAs on peptides that have known binding affinities to MHC molecules. Both SVMs and ANNs have been used in this context. SVM regression has been applied by Liu et al. [78] to predict peptide binding affinity to MHCI molecules. These models are available at the SVRMHC site ( Table I) . ANNs were shown to perform sensitive predictions of peptide binding affinity to MHCI molecules by Buus et al. [79] and are implemented using the NetMHC method ( Table I ). The NetMHC method was latter improved by Nielsen et al. [80] , who trained ANNs using combinations of novel input representations (sparse encoding, blosum encoding, and input that was derived from HMMs).
As noted, MHC binding predictions are limited by the availability of experimental peptide binding data. Ingeniously, by combining MHCI peptide binding residues and peptide binding affinity data as input information for training the ANNs, Nielsen et al. [81] developed the NetMHCpan method (Table I) , which can predict peptide binding affinities to uncharacterized MHCI molecules. Nielsen et al. [82] also followed a similar approach in developing the NetMHCIIpan method (Table I) , which predicts binding affinities of peptides to HLA-DR molecules with little or no binding data. The NetMHCIIpan predictive models were obtained from MHCII-peptide binding sequences of known binding affinity that were preprocessed with the SMM-align method and, in combination with the HLA-DR residues that make contact with the peptide, used as input data for training ANNs.
Structure-Based Quantitative Methods
Several groups have combined peptide binding data with 3D-structural information of MHC molecules to predict peptide binding affinities. To this end, Doytchinova and Flower [83] used a powerful molecular comparative similarity index analysis (CoMSIA) to predict the binding affinity of peptides to MHCI. The combination of 3D-structural information and peptide binding data can generate models that extrapolate peptide binding affinity predictions to MHC molecules for which very little binding data exist, as has been shown recently by Jojic et al. [84] using an adaptive double threading approach ( Table I) .
Modeling-Based Methods
In this category, we include methods that are not trained on any binding data and are solely based on the 3D structure of the MHC molecule; hence, they are often known as structure-based methods. However, we have classified them as modeling-based methods for two reasons: 1) as has been shown, there are other methods that use 3D-structural information of MHC molecules but in combination with peptide binding data; and 2) the 3D structure of most MHC molecules is not known but can be modeled or simulated. Modeling-based methods for predicting MHC-peptide binding are less accurate than data-driven models. Yet, they have the greatest potential, because they can be applied to any MHC molecule.
The first approach that was used to predict MHC-peptide binding was based on molecular dynamics simulations (MDSs) [85] . This method was computationally intensive and when it was tested on HLA-B*2705, it allowed only a crude discrimination between binders and non-binders. Altuvia et al. [86] introduced a structure-based algorithm to predict peptide binding to HLA-A*0201 that was considerably faster and more accurate. The algorithm consisted of fitting the peptide in the binding groove of the MHCIpeptide threading-and evaluating MHCI-peptide pairwise interactions using the knowledge-based potential matrix of Miyazawa and Jernigan [87] . This matrix, however, was only useful to predict the binding of peptides to MHCI molecules that had hydrophobic binding pockets but not to those with hydrophilic or charged pockets. In response to these limitations, Zhao et al. [88] and Schueler-Furman [89] developed novel knowledge-based potential matrices, which allowed to predict peptide binding to most MHCI molecules using to peptide threading. Recently, Mohanapriya et al. [90] also used peptide threading to predict peptide binding to MHCII molecules. Docking or computer-simulated ligand binding has also been used to predict MHC-peptide binding. Docking methods use energy-scoring functions to calculate the binding energy of a series of ligand candidates. In this regard, Logean et al. [91] developed a tailor-made energy scoring function (FRESNO) to predict peptide binding to MHCI molecules. Peptide threading and docking methods do not perform exhaustive figurations of the MHC-peptide structure. Nevertheless, accurate prediction of MHC-peptide structures can certainly improve the accuracy of peptide binding predictions and relevant efforts have been made to model the appropriate geometry of MHCI-and MHCIIbound peptides [92] [93] [94] [95] [96] .
MHC SUPERTYPES
The development of T cell epitope-based vaccines with wide population coverage is significantly hindered by HLA polymorphisms; they generally determine the peptide binding specificity of MHC molecules [9] . Therefore, grou- Fig. (2) . Classification of MHC-peptide binding prediction methods. This figure shows a schematic overview of the different methods for predicting MHC-peptide binding according to the data used for training. Pattern Binding Recognition Models can also be generated using techniques that require only one class of data (e.g., peptides known to bind to a given MHC molecule).
ping MHC molecules into supertypes, based on similarities in peptide binding specificity, is useful to optimize the composition of epitope-based vaccines.
MHC supertypes were first identified by Sette and Sidney [97, 98] , who, by inspecting HLA I allele-specific binding motifs, recognized that most HLA I alleles could be classified into nine supertypes. Further, they observed that 88% of the population expressed the alleles of just three supertypes (HLA-A2, HLA-A3, and HLA-B7). Subsequently, other more sophisticated computational approaches have emerged to classify HLA I and HLA II alleles, which have served to refine and expand the original supertypes defined by Sette and Sidney [97, 98] . Reche and Reinherz [99, 100] described a method for defining MHC supertypes by clustering MHC allelic-specific peptide binding repertories and Lund et al. [101] reported a similar method by clustering peptide binding matrices. These methods for identifying MHC supertypes are limited by the availability of allele-specific predictors of peptide binding. In contrast, Doytchinova et al. [102] [103] [104] have reported a system to classify into supertypes all HLA I and HLA II allelic variants, which is solely based on the 3D structure of MHC molecules. Similarly, Kangueane et al. [105] recognized that all HLA-A, -B, and -C alleles can be grouped into supertypes on the basis of several critical polymorphic residues.
COMPARING THE METHODS FOR PREDICTING MHC-PEPTIDE BINDING
Peptide-data driven models overwhelmingly outperform modeling-based methods. Despite the focus of many studies on evaluating the success of various MHC-peptide binding prediction methods, there is no consensus on the ideal method. This controversy arises because the predictive performance of the methods varies for different MHC molecules and evaluation test sets. Moreover, the value of comparative evaluations between pattern recognition models and regression models must be examined with caution, because a regression model can be used to predict whether a peptide binds to MHC, but a pattern recognition model cannot predict binding affinities. Therefore, peptide scores that are obtained using pattern recognition models should not be correlated with binding affinities.
Often predictive methods based on ANNs and SVMs are described as superior methods, because they can model binding interferences between peptide side chains. However, using a benchmark of peptides of known binding affinities to MHCI, Gulukota et al. [43] found that modeling peptide side chain interactions using ANNs only improved marginally the predictions obtained with QMs, which assume an independent binding contribution of each peptide residue [43] . In another study, Yu et al. [106] compared the efficacy of simple sequence motifs, SYFPEITHI motif matrices [27] , ANN-based classification models, HMMs, and BIMAS-QMs to predict peptide binding to MHC, concluding that ANNbased classification models and HMMs were superior when trained on large datasets (more than 50 peptides). The HMMs that were used in this evaluation were profile HMMs generated from ungapped alignments of peptides. As noted, such HMMs are equivalent to profile PSSMs [107] and both should share the same detection and predictive powers, provided that they are generated from the same peptides. HMMs are superior to profile PSSMs only when they are derived from gapped alignments. Interestingly, Yu et al. [106] also found that despite the inferiority of simple sequence motifs to the other methods, they were the best predictors when the training sets consisted of merely several peptides.
Peters et al. [108] also performed a comparative validation using a benchmark that consisted of peptides of known affinities to different MHCI molecules. These authors found that SMM-QMs and ANN-based regression models performed better than ARB-QMs and BIMAS-QMs. They also reported that SYFPEITHI motif matrices [27] are poor predictors of peptide binding affinity, as one would expect. More recently, Lin et al. [109] evaluated several methods for predicting peptide binding affinity to MHCII using a benchmark of peptides of known binding affinities to MHCII wherein NetMHCIIpan was judged to be the best predictor, followed by PROPRED (TEPITOPE QMs).
WEB SERVERS AND DATABASES
The methods for predicting MHC-peptide binding that have been described in this article and are available for public use on the Internet are listed on Table I . All of the methods in Table I have been developed under crossvalidation; therein, choosing the right tool for predicting MHC-peptide binding is not straightforward. However, one must know whether a specific method predicts binding affinities or merely qualitative binding (binding pattern recognition models).
Prediction rates obtained with any of these methods generally vary for the different MHC molecules. Moreover, not a single method has yet to yield reasonably accurate predictions for all MHC molecules. Therefore, users should make use of these web-based methods as frameworks to carry their own computational experiments and test the performance for the MHC molecule of interest. To this end, users should refer to their own sets of MHC-binding peptides, which can be obtained from public resources such as those listed in Table II . Web-based prediction tools should themselves facilitate computational experimentation, providing results that are easy to interpret and in formats that can be easily downloaded and processed for further analysis by users.
CONCLUDING REMARKS
The prediction of MHC-peptide binding is the basis for anticipating T cell epitopes. The identification of T cell epitopes requires laborious and costly experiments, and the prediction of MHC-peptide binding significantly decrease these experimental burdens. In recent years, there has been tremendous growth of methods that predict MHC-peptide binding, and significant progress has been reported with regard to their in silico predictive accuracy and the range of MHC molecules that can be targeted for peptide binding predictions.
In practice, however, the prediction of MHC-peptide binding is far from perfect. For example, in a recent study, Wang et al. [110] predicted 167 9-mer peptides from influenza A virus (IAV) as potential binders of various HLA I alleles, using NetMHC [79, 80] . Subsequently, these authors tested binding and only 89 peptides (53% of the pool) were classified as authentic binders; 39 failed to bind altogether, and another 39 bound very weakly. Of the successful binders, only 13 peptides elicited T cell responses (real T cell epitopes) (7.8% of their total predicted peptide pool). A similar discovery ratio of IAV-specific CD8 T cell epitopes restricted by K b and D b was reported by Zhong et al. [111] using SYFPEITHI motif matrices [27] . This low epitope-discovery rate is, however, deceiving, because MHC-peptide binding predictions do not substitute for experimental work but merely complement it. Thus, an alternative approach would have required to make and test over 4000 9-mers constituting the IAV proteome that, based on size, can bind to MHC. However, a reasonable question arises with regard to the use of MHC-peptide binding prediction methods: Do they overlook any true MHC-binding peptides?
Overall, the results that we have discussed indicate that predicting MHC-peptide binding is vital for epitope identification but remains challenging with ample room for improvement. Furthermore, the gap between the peptides that are predicted to bind to MHC and those that experimental turn out to bind, implies that new evaluation benchmarks and experimental data are required. Indeed, we believe the field will benefit from launching a Critical Assessment of Techniques for MHC-peptide binding/ Epitope Prediction, similar to the Critical Assessment of Techniques for Protein Structure (CAPS). Under this program, computational methods will be used for blind de novo prediction of peptides that bind to MHC from query proteins that, for evaluation purposes, have been experimentally screened for MHC-peptide binding. Given the synergy between peptide data and MHC-peptide binding predictions, this endeavor will undoubtedly serve to improve the accuracy of MHC-peptide binding prediction methods. 
